Frontlight ResearchEarly access
Spinal muscular atrophy trials in United Kingdom
4 of 12 trials · From ClinicalTrials.gov, checked 18 November 2026. Ask the study team whether a trial fits you.
- No phaseTaking peopleStudy of an Intrathecal Port and Catheter System for Subjects With Spinal Muscular Atrophy
- Where
- Sheffield
- Age
- 3 years and over
- People
- 90 worldwide
- Run by
- Alcyone Therapeutics, Inc
See details and how to joinNCT05866419 - Phase 2Taking peopleA Study to Assess the Safety, Tolerability, Efficacy, Pharmacokinetics, and Immunogenicity of Intravenous Administration of ARGX-119 in Pediatric Participants Aged 5 to Less Than 18 Years With Spinal Muscular Atrophy
- Where
- Birmingham, Cambridge, Glasgow, Leeds, London, Oxford, Sheffield
- Age
- 5 years to 17 years
- People
- 60 worldwide
- Run by
- argenx
See details and how to joinNCT07287982 · EU 2025-523496-32-00 - Phase 2Taking peopleA Study to Evaluate How Apitegromab Works in Subjects Who Are Less Than 2 Years Old and Have Spinal Muscular Atrophy
- Where
- Leeds
- Age
- Up to 2 years
- People
- 52 worldwide
- Run by
- Scholar Rock, Inc.
See details and how to joinNCT07047144 - Phase 1Taking peopleA Study to Find Out How Nusinersen is Processed in the Body When Given Through the ThecaFlex DRx™ System in Adult and Pediatric Participants With Spinal Muscular Atrophy (PIERRE-PK)
- Where
- Sheffield
- Age
- 3 years and over
- People
- 78 worldwide
- Run by
- Biogen
See details and how to joinNCT06555419 · EU 2024-514239-21-00